Sagefield Capital’s Lux Health Tech Acquisition Corp. Class A Common Stock LUXA Stock Holding History

Sagefield Capital’s Portfolio LUXA Stock Details LUXA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-19,000	Closed	-$190K	–	135
2022 Q3	$190K	Hold	19,000	–	–	0.06%	114
2022 Q2	$188K	Hold	19,000	–	–	0.09%	109
2022 Q1	$187K	Hold	19,000	–	–	0.08%	106
2021 Q4	$186K	Buy	+19,000	New	+$187K	0.09%	105

Sagefield Capital's LUXA Position: Q4 2022 in Review

Sagefield Capital sold out of Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) in Q4 2022, closing a stake of 19,000 shares — an estimated $190K sold.

Sagefield Capital first reported a position in LUXA in Q4 2021 and held it in 4 quarters. The position peaked at $190K in Q3 2022. 0 funds tracked by Wall St. Rank hold LUXA as of Q4 2022.

Sagefield Capital reported no remaining Lux Health Tech Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Sagefield Capital sold 19,000 Lux Health Tech Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $190K.
Sagefield Capital first reported a position in Lux Health Tech Acquisition Corp. Class A Common Stock in Q4 2021 and held it in 4 quarters.
Sagefield Capital's Lux Health Tech Acquisition Corp. Class A Common Stock position peaked at $190K in Q3 2022.
0 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on Sagefield Capital's 13F filing for Q4 2022, filed 14 Feb 2023.